A.
|
Full title of the plan and the address of the plan, if different from that of the issuer named below:
|
B.
|
Name of issuer of the securities held pursuant to the plan and the address of its principal executive office:
|
MINERALS TECHNOLOGIES INC.
SAVINGS AND INVESTMENT PLAN Statements of Net Assets Available for Benefits (in thousands) |
||||||||
|
||||||||
December 31,
|
||||||||
2021
|
2020
|
|||||||
Assets:
|
||||||||
Investments, at fair value (note 3):
|
||||||||
Cash equivalents
|
$
|
1,279
|
$
|
2,202
|
||||
In securities of participating employer
|
41,380
|
36,901
|
||||||
In securities of unaffiliated issuers:
|
||||||||
Common stock
|
15,669
|
10,276
|
||||||
Common collective funds
|
119,255
|
102,601
|
||||||
Mutual funds
|
120,242
|
114,203
|
||||||
Total investments, at fair value
|
297,825
|
266,183
|
||||||
Fully benefit–responsive investment contracts, at contract value
|
65,023
|
63,457
|
||||||
Notes receivable from participants
|
4,940
|
5,094
|
||||||
Net assets available for benefits
|
$
|
367,788
|
$
|
334,734
|
||||
See accompanying notes to the financial statements.
|
MINERALS TECHNOLOGIES INC.
SAVINGS AND INVESTMENT PLAN Statements of Changes in Net Assets Available for Benefits (in thousands) |
||||||||
Year Ended December 31,
|
||||||||
2021
|
2020
|
|||||||
Additions to net assets attributed to:
|
||||||||
Investment income:
|
||||||||
Net appreciation in fair value of investments
|
$
|
48,501
|
$
|
30,680
|
||||
Dividends
|
2,134
|
2,125
|
||||||
Interest
|
1,228
|
1,357
|
||||||
Investment income
|
51,863
|
34,162
|
||||||
Interest from notes receivable from participants
|
246
|
261
|
||||||
Contributions:
|
||||||||
Participants
|
11,981
|
12,584
|
||||||
Employer
|
6,000
|
6,006
|
||||||
Total contributions
|
17,981
|
18,590
|
||||||
Total additions
|
70,090
|
53,013
|
||||||
Reductions from net assets attributed to:
|
||||||||
Benefits paid to participants
|
36,771
|
32,197
|
||||||
Administrative expenses
|
265
|
186
|
||||||
Total reductions
|
37,036
|
32,383
|
||||||
Net increase
|
33,054
|
20,630
|
||||||
Net assets available for benefits:
|
||||||||
Beginning of year
|
334,734
|
314,104
|
||||||
End of year
|
$
|
367,788
|
$
|
334,734
|
||||
See accompanying notes to the financial statements.
|
(1)
|
Description of Plan
|
The following description of the Minerals Technologies Inc. Savings and Investment Plan (the “Plan”) provides only general information. Participants should refer to the Plan agreement for a more complete
description of the Plan's provisions.
|
|
General
|
|
The Plan is a defined contribution plan sponsored by Minerals Technologies Inc. (the “Plan Sponsor” or “Company”). Employees who generally work more than 20 hours per week become eligible to participate in the
Plan on the date of their employment.
|
|
The Plan is subject to the provisions of the Employee Retirement Income Security Act of 1974, as amended (“ERISA”).
|
|
Contributions
|
|
Participants may elect to contribute between 2% and 20% of eligible earnings (as defined). Contributions may be made on a pre-tax basis, on an after-tax basis, or on a combined basis. Employee contributions of
the first 3% of the participant’s eligible contributions will be matched 100% by the Company and the next 2% will be matched 50% by the Company to a maximum compensation limit of $290,000. Employee contributions in excess of 5% will not be
matched. While it is the Company’s intention to make matching contributions each payroll period, the Company’s Board of Directors reserves the right to increase, reduce or eliminate matching contributions for any Plan year, or for any payroll
period. The Company's matching contributions are invested solely in the Company's common stock. Participants can, at any time, transfer or reallocate amounts held in the MTI Common Stock Fund to another fund under the Plan. Certain employees
of AMCOL International, hired after December 31, 2003 through the merger date receive a special retirement contribution of 3% of compensation.
Employees initially eligible to participate in the Plan on or after January 1, 2012 will be automatically enrolled at a 3% contribution rate. Newly eligible participants have approximately 45 days from their
initial eligibility date to choose a different pre-tax percentage, contribute on an after-tax basis or to opt not to participate in the Plan.
|
|
Participants may also contribute amounts representing distributions from other qualified defined benefit or defined contribution plans. Participants direct the investment of their contributions into various
investment options offered by the Plan. The maximum before-tax contribution limit for participants under age 50 was $19,500 for both 2021 and 2020, respectively. However, a participant's contributions may be further increased or reduced
based on the rules and regulations of the Internal Revenue Code (“IRC”). All eligible employees who are projected to attain age 50 before the end of the year will be eligible to make pre-tax catch-up contributions in accordance with certain
regulations.
|
|
Participant Accounts
|
|
Each participant's account is credited with the participant's contributions and allocations of (a) the Company's contributions and (b) Plan earnings or loss, and charged with an allocation of administrative
expenses. Allocations are based on participant earnings or account balances, as defined. The benefit to which a participant is entitled is the benefit that can be provided from the participant's account.
|
|
Vesting
|
|
Participants are fully vested in the entire value of their accounts at the time of contribution.
|
|
Investment Options
|
|
Each participant in the Plan elects to have contributions invested in any one or a combination of the following separate investment options as of December 31, 2021:
|
|
New York Life Insurance Anchor Account IV: This fund is a New York Life Insurance Company pooled separate account which invests in fixed income securities.
|
|
BlackRock US Government Bond Portfolio: This fund invests in bonds backed by the U.S. government or by government-linked agencies.
|
|
Prudential Total Return Bond Fund: This fund invests primarily in bonds.
|
State Street Target Retirement Non-Lending Series Funds (The Strategy Funds): These funds are designed to incorporate a broad range of asset classes to provide diversification of returns and risks
consistent with a stated time horizon. The Strategy Funds asset mix becomes progressively more conservative over time as the strategy target date grows nearer. The strategy target dates range from 2020 to 2065. There is also an age-based
lifetime strategy fund. The investments are in a combination of U.S. stocks, international stocks, bonds and cash.
|
|
Alliance Bernstein Discovery Value Fund: This fund invests primarily in small and mid-capitalization stocks.
|
|
American Funds - Fundamental Investors Fund: This fund invests primarily in common stocks and may invest significantly in securities of issuers domiciled outside the U.S. and Canada and not included in
the S&P 500 Index.
|
|
Black Rock Equity Index Fund: This fund invests in the same stocks held in the S & P 500 Index.
|
|
Eaton Vance AtlCapSMID-Cap: This fund invests primarily in small and mid-capitalization stocks.
|
|
ClearBridge Large Cap Growth Fund (IS): This fund seeks long-term capital growth. This fund invests at least 80% of its net assets in equity securities or other instruments with similar economic
characteristics of U.S. companies with large market capitalizations.
|
|
Janus Henderson Balanced Fund (N): This fund is invested in stocks and bonds.
Janus Triton Fund (I): This fund invests in equity securities of small and medium-sized companies.
|
|
MFS International Value R4 Fund: This fund primarily invests its assets in foreign equity securities, including emerging market equity securities.
MFS International Value R6 Fund: This fund primarily invests its assets in foreign equity securities, including emerging market equity securities.
|
|
Vanguard Life Strategy Conservative Growth Fund: This fund is invested in stocks, bonds and cash equivalents. Approximately 60% of the fund’s assets are invested in bonds and 40% in common stocks and
cash equivalents.
|
|
Vanguard Life Strategy Growth Fund: This fund is primarily invested in stocks and bonds. Approximately 80% of the fund’s assets are invested in stocks and 20% in bonds.
|
|
Vanguard Life Strategy Moderate Growth Fund: This fund is invested in stocks, bonds and cash equivalents. Approximately 60% of the fund is invested in mid and large capitalization stock and 40% in fixed
income securities and cash equivalents.
Wilmington Large Cap Value Fund: This fund invests in a diversified portfolio of U.S. equity (or equity-related) securities of large-cap companies (primarily common stock).
|
|
State Street Russell Small/Midcap Index Non-Lending Series Fund: This fund is designed to match the risk and return of the Russell 2000 Index, a broadly based average of the U.S. equity market.
|
|
State Street S&P Midcap 400 Index Securities Lending Series Fund: This fund is designed to match the risk and return of the Standard & Poor's 400 Index, a broadly based average of the U.S. equity
market.
|
|
MTI Common Stock Fund: This fund invests in the Company's common stock. The MTI Common Stock Fund is a participant-directed fund. All Company matching contributions are invested in this fund, and once
deposited; the investments are participant-directed.
|
|
Pfizer Common Stock Fund: This fund invests in the common stock of Pfizer Inc. The fund holds contributions to the Pfizer Common Stock Fund, which were transferred from Pfizer Inc. when the Plan was
established. No new contributions or transfers can be made into this fund, however, participants are allowed to transfer balances from this fund into other investment options.
|
|
TD Ameritrade Participant-Directed Brokerage Account: This is a participant-directed brokerage account which invests primarily in a variety of publicly available mutual funds, common stock and cash and
cash equivalents.
|
(3)
|
Fair Value Measurements
|
There is a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. These tiers include: Level 1, defined as observable inputs such as quoted prices in active markets; Level
2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable; and Level 3, defined as unobservable inputs about which little or no market data exists, therefore requiring an entity to
develop its own assumptions.
|
The following is a description of the valuation methodologies used for assets measured at fair value. There have been no changes in the methodologies used at December 31, 2021 or 2020.
|
Equity securities: The fair value is based on the unadjusted closing price reported on the active market on which the security is traded and is classified within Level 1
of the fair value hierarchy.
|
|
Mutual funds: Registered investment companies are public investment vehicles valued using net asset value (“NAV”) provided by the administrator of the mutual fund.
These securities are valued using quoted market prices. The NAV is an unadjusted quoted price on an active market and classified within Level 1 of the fair value hierarchy.
|
|
Common collective funds: Valued at the fair value using the NAV provided by the fund trustee as a practical expedient based on
the value of the underlying assets owned by the trust, minus its liabilities, and then divided by the number of shares outstanding. There are no imposed redemption restrictions nor does the Plan have any contractual obligations to further
invest in the common collective trust funds. There are no unfunded commitments. The NAV for these funds are published on a daily basis and is the basis for the Plan participant transactions. In accordance with subtopic 820-10,these
investments have not been classified in the fair value hierarchy. The amounts presented in the fair value table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the statements of assets available
for benefits.
|
|
Cash equivalents: The carrying value approximates fair value and is classified within Level 1 of the fair value hierarchy.
|
The following tables sets forth by level, the Plan's financial assets at fair value as of December 31, 2021 and 2020. Assets and liabilities are classified in their entirety based on the lowest level of input
that is significant to the fair value measurement. The Company's assessment of the significance of a particular input to the fair value measurement requires judgment and may affect the valuation of fair value assets and liabilities and their
placement within the fair value hierarchy levels. The method described above may produce a fair value that may not be indicative of net realizable value or reflective of future fair value. There were no transfers between fair value levels
during 2021 and 2020.
|
As of December 31, 2021
(dollars in thousands)
|
||||||||||||||||
Investments at Fair Value as determined by Quoted or Published Prices in active markets (Level I)
|
Valuation techniques based on observable market data (Level II)
|
Valuation techniques incorporating information other than observable market data (Level III)
|
Total Investments measured at Fair Value at December 31, 2021
|
|||||||||||||
Cash equivalents
|
$
|
1,279
|
$
|
--
|
$
|
--
|
$
|
1,279
|
||||||||
Mutual funds
|
||||||||||||||||
Fixed income funds
|
$
|
12,604
|
$
|
--
|
$
|
--
|
$
|
12,604
|
||||||||
Equity funds
|
$
|
48,149
|
$
|
--
|
$
|
--
|
$
|
48,149
|
||||||||
Growth & income funds
|
$
|
57,911
|
$
|
--
|
$
|
--
|
$
|
57,911
|
||||||||
Mutual funds - participant-directed brokerage account
|
||||||||||||||||
Equity funds –capital growth
|
$
|
1,247
|
$
|
--
|
$
|
--
|
$
|
1,247
|
||||||||
Equity funds – current income
|
$
|
184
|
$
|
--
|
$
|
--
|
$
|
184
|
||||||||
Balanced funds
|
$
|
118
|
$
|
--
|
$
|
--
|
$
|
118
|
||||||||
Fixed income funds
|
$
|
18
|
$
|
--
|
$
|
--
|
$
|
18
|
||||||||
International funds
|
$
|
11
|
$
|
--
|
$
|
--
|
$
|
11
|
||||||||
Total mutual funds
|
$
|
120,242
|
$
|
--
|
$
|
--
|
$
|
120,242
|
||||||||
Common stock
|
||||||||||||||||
Participant-directed brokerage account
|
$
|
788
|
$
|
--
|
$
|
--
|
$
|
788
|
||||||||
Pharmaceuticals
|
$
|
14,881
|
$
|
--
|
$
|
--
|
$
|
14,881
|
||||||||
Industrial
|
$
|
41,380
|
$
|
--
|
$
|
--
|
$
|
41,380
|
||||||||
Total common stock
|
$
|
57,049
|
$
|
--
|
$
|
--
|
$
|
57,049
|
||||||||
Investments at NAV
|
$
|
--
|
$
|
--
|
$
|
--
|
$
|
119,255
|
||||||||
Total investments
|
$
|
178,750
|
$
|
--
|
$
|
--
|
$
|
297,825
|
As of December 31, 2020
(dollars in thousands)
|
||||||||||||||||
Investments at Fair Value as determined by Quoted or Published Prices in active markets (Level I)
|
Valuation techniques based on observable market data (Level II)
|
Valuation techniques incorporating information other than observable market data (Level III)
|
Total Investments measured at Fair Value at December 31, 2020
|
|||||||||||||
Cash equivalents
|
$
|
2,202
|
$
|
--
|
$
|
--
|
$
|
2,202
|
||||||||
Mutual funds
|
||||||||||||||||
Fixed income funds
|
$
|
14,568
|
$
|
--
|
$
|
--
|
$
|
14,568
|
||||||||
Equity funds
|
$
|
43,994
|
$
|
--
|
$
|
--
|
$
|
43,994
|
||||||||
Growth & income funds
|
$
|
54,180
|
$
|
--
|
$
|
--
|
$
|
54,180
|
||||||||
Mutual funds - participant-directed brokerage account
|
||||||||||||||||
Equity funds –capital growth
|
$
|
1,158
|
$
|
--
|
$
|
--
|
$
|
1,158
|
||||||||
Equity funds – current income
|
$
|
96
|
$
|
--
|
$
|
--
|
$
|
96
|
||||||||
Balanced funds
|
$
|
101
|
$
|
--
|
$
|
--
|
$
|
101
|
||||||||
Fixed income funds
|
$
|
94
|
$
|
--
|
$
|
--
|
$
|
94
|
||||||||
International funds
|
$
|
12
|
$
|
--
|
$
|
--
|
$
|
12
|
||||||||
Total mutual funds
|
$
|
114,203
|
$
|
--
|
$
|
--
|
$
|
114,203
|
||||||||
Common stock
|
||||||||||||||||
Participant-directed brokerage account
|
$
|
707
|
$
|
--
|
$
|
--
|
$
|
707
|
||||||||
Pharmaceuticals
|
$
|
9,569
|
$
|
--
|
$
|
--
|
$
|
9,569
|
||||||||
Industrial
|
$
|
36,901
|
$
|
--
|
$
|
--
|
$
|
36,901
|
||||||||
Total common stock
|
$
|
47,177
|
$
|
--
|
$
|
--
|
$
|
47,177
|
||||||||
Investments at NAV
|
$
|
--
|
$
|
--
|
$
|
--
|
$
|
102,601
|
||||||||
Total investments
|
$
|
163,582
|
$
|
--
|
$
|
--
|
$
|
266,183
|
(4)
|
Fully Benefit Responsive Contract
|
The Plan invests in the New York Life Insurance Anchor Acct IV, which is considered a fully benefit responsive contract (the “Contract”). This investment is valued at contract value reported by the fund
manager based on the underlying investments within each fund. There are no imposed redemption restrictions.
The average yield of the underlying assets earned by the Plan from the New York Life Insurance Anchor Account IV was 2.12% and 2.32% at December 31, 2021 and 2020, respectively. The average crediting interest
rate was 1.77% and 1.98% at December 31, 2021 and 2020, respectively.
The existence of certain conditions can limit the Contract's ability to transact at contract value with the issuers of its investment contracts. Specifically, any event outside the normal operation of the
Contract that causes a withdrawal from an investment contract may result in a negative market value adjustment with respect to such withdrawal. Examples of such events include, but are not limited to, partial or complete legal termination of
the Contract or a unitholder, tax disqualification of the Contract or a unitholder, and certain Contract amendments if issuers' consent is not obtained. As of December 31, 2021, the occurrence of an event outside the normal operation of the
Contract that would cause a withdrawal from an investment contract is not considered to be probable. To the extent a unitholder suffers a tax disqualification or legal termination event, under normal circumstances it is anticipated that
liquid assets would be available to satisfy the redemption of such unitholder's interest in the Contract without the need to access investment contracts.
|
|
(5)
|
Plan Termination
|
Although it has not expressed any intent to do so, the Company has the right under the Plan to discontinue its contributions at any time and to terminate the Plan by action of the Company's Board of Directors,
subject to the provisions of ERISA. Upon termination of the Plan, each participant thereby affected would receive the entire value of his or her account as of the date of such termination. No part of the assets in the investment funds
established pursuant to the Plan would at any time revert to the Company.
|
|
(6)
|
Tax Status
|
The Internal Revenue Service (“IRS”) determined and informed the Company by a letter dated December 27, 2013, that the Plan and related Trust established thereunder are properly designed and, thus qualified and
are tax exempt, respectively, within the meaning of Sections 401(a) and 501(a) of the Internal Revenue Code (“IRC”). Although the Plan has been amended and restated since receiving the determination letter, the Company and legal counsel
believe that the Plan is designed and is currently being operated in compliance with the applicable requirements of the IRC.
U.S. GAAP requires plan management to evaluate tax positions taken by the Plan and recognize a tax liability (or de-recognize an asset) if the Plan has taken an uncertain position that more likely than not
would not be sustained upon examination by the IRS. The plan administrator has analyzed the tax positions taken by the Plan, and has concluded that as of December 31, 2021 and 2020, there are no uncertain tax positions taken or expected to
be taken that would require recognition of a liability (or de-recognition of an asset) or disclosure in the financial statements. The Plan is subject to routine audits by taxing jurisdictions; however, there are currently no audits for any
tax periods in progress. The plan administrator believes it is no longer subject to income tax audits for years prior to 2018.
|
|
(7)
|
Administrative and Investment Advisor Costs
|
All costs of administering the Plan are paid by the Plan and amounted to $265,042 and $186,574 for the years ended December 31, 2021 and 2020, respectively. Participants are responsible for any origination and
maintenance fees for each loan, and certain expenses for participating in the participant directed brokerage account. Investment advisers are reimbursed for costs incurred or receive a management fee for providing investment advisory
services. Investment advisory fees and costs are deducted and reflected in the net appreciation in the fair value of investments on the Statements of Changes in Net Assets Available for Benefits.
|
(8)
|
Related-Party Transactions
|
John Hancock Trust Company LLC is Trustee and record keeper of the Plan. Certain Plan investments in the pooled separate account are managed by New York Life Investment Management LLC, an affiliate of John
Hancock Trust Company LLC.
|
|
Certain Plan investments are shares of the Company's common stock, which qualify as party-in-interest transactions.
|
|
(9)
|
Concentration of Risks and Uncertainties
|
The Plan's exposure to a concentration of credit risk is limited by the diversification of investments across several participant-directed fund elections. Additionally, the investments within each
participant-directed fund election are further diversified into varied financial instruments, with the exception of the MTI and Pfizer Common Stock Funds, which principally invest in securities of a single issuer.
|
|
The Plan investments include a number of investment options including MTI and Pfizer common stock and a variety of investment funds, some of which are mutual funds or common collective funds. Investment
securities, in general, are exposed to various risks, such as interest rate, credit, and overall market volatility risk. Due to the level of risk associated with certain investment securities, it is reasonably possible that changes in the
values of investment securities will occur in the near term and that such changes could materially affect the amounts reported in the statements of net assets for benefits and participant account balances. Plan investments included a variety
of investment that may directly or indirectly invest in securities with contractual cash flows. The value, liquidity, and related income of these securities are sensitive to changes in economic conditions and may be adversely affected by
shifts in the market’s perception of the issuers and changes in interest rates.
|
|
(10)
|
Subsequent Events
|
The Plan evaluated events subsequent to December 31, 2021 and through June 14, 2022, the date on which the financial statements were issued, and determined there have not been any events that have occurred that
would require adjustment to or disclosure in the financial statements.
|
|
(11)
|
Coronavirus Aid, Relief, and Economic Security (CARES) Act
|
On March 27, 2020, the CARES Act was signed into law and, among other things, included several relief provisions available to tax-qualified retirement plans and their participants. Plan management evaluated the
relief provisions available to plan participants under the CARES Act, however elected not to adopt any of the provisions for Plan years ended December 31, 2021 and December 31, 2020.
|
(a)
|
(b)
|
(c)
|
(d)
|
(e)
|
||||||||||||
Identity of issue, borrower,
lessor or similar party |
Description of investment/interest
|
Cost
|
Current Value
|
|||||||||||||
Cash Equivalents:
|
||||||||||||||||
PIMCO Government Money Market
|
Money market account
|
$
|
648
|
$
|
648
|
|||||||||||
TD Ameritrade Participant-Directed Brokerage Account
|
Various money market accounts
|
$
|
631
|
$
|
631
|
|||||||||||
Total Cash Equivalents
|
$
|
1,279
|
$
|
1,279
|
||||||||||||
Fully benefit responsive investment contract, at contract value:
|
||||||||||||||||
*
|
New York Life Insurance Anchor Acct IV
|
55,656
|
units
|
$
|
62,097
|
$
|
65,023
|
|||||||||
Common Collective Funds:
|
||||||||||||||||
Target Retirement 2020 Strategy
|
||||||||||||||||
State Street Target Retirement 2020 Securities Non-Lending Series Fund
|
83
|
units
|
$
|
1,577
|
$
|
2,056
|
||||||||||
Target Retirement 2025 Strategy
|
||||||||||||||||
State Street Target Retirement 2025 Securities Non-Lending Series Fund
|
379
|
units
|
$
|
7,587
|
$
|
10,510
|
||||||||||
Target Retirement 2030 Strategy
|
||||||||||||||||
State Street Target Retirement 2030 Securities Non-Lending Series Fund
|
266
|
units
|
$
|
5,873
|
$
|
7,854
|
||||||||||
Target Retirement 2035 Strategy
|
||||||||||||||||
State Street Target Retirement 2035 Securities Non-Lending Series Fund
|
192
|
units
|
$
|
4,167
|
$
|
5,960
|
||||||||||
Target Retirement 2040 Strategy
|
||||||||||||||||
State Street Target Retirement 2040 Securities Non-Lending Series Fund
|
129
|
units
|
$
|
2,805
|
$
|
4,031
|
||||||||||
Target Retirement 2045 Strategy
|
||||||||||||||||
State Street Target Retirement 2045 Securities Non-Lending Series Fund
|
174
|
units
|
$
|
3,964
|
$
|
5,555
|
||||||||||
Target Retirement 2050 Strategy
|
||||||||||||||||
State Street Target Retirement 2050 Securities Non-Lending Series Fund
|
114
|
units
|
$
|
2,579
|
$
|
3,648
|
||||||||||
Target Retirement 2055 Strategy
|
||||||||||||||||
State Street Target Retirement 2055 Securities Non-Lending Series Fund
|
127
|
units
|
$
|
2,084
|
$
|
2,752
|
||||||||||
Target Retirement 2060 Strategy
|
||||||||||||||||
State Street Target Retirement 2060 Securities Non-Lending Series Fund
|
15
|
Units
|
$
|
256
|
$
|
294
|
(a)
|
(b)
|
(c)
|
(d)
|
(e)
|
||||||||||
Identity of issue, borrower,
lessor or similar party |
Description of investment/interest
|
Cost
|
Current Value
|
|||||||||||
Target Retirement 2065 Strategy
|
||||||||||||||
State Street Target Retirement 2065 Securities Non-Lending Series Fund
|
8
|
Units
|
$
|
93
|
104
|
|||||||||
Target Retirement Income Strategy
|
||||||||||||||
SSgA Target Retirement Income Non-Lending Series Fund
|
91
|
Units
|
1,392
|
1,771
|
||||||||||
Black Rock Equity Index Fund
|
906
|
units
|
$
|
23,199
|
$
|
52,959
|
||||||||
State Street Russell Small/Midcap Index Non-Lending Series Fund
|
61
|
units
|
$
|
3,758
|
$
|
5,506
|
||||||||
State Street S&P Midcap 400 Index Securities Lending Series Fund
|
53
|
units
|
$
|
5,759
|
$
|
8,897
|
||||||||
Wilmington Large Cap Value Fund
|
461
|
units
|
$
|
5,150
|
$
|
7,358
|
||||||||
Total Common Collective Funds
|
$
|
70,243
|
$
|
119,255
|
Mutual Funds:
|
|||||||||||||||||
Alliance Bernstein Discovery Value Fund
|
88
|
units
|
$
|
1,920
|
$
|
2,200
|
|||||||||||
American Funds - Fundamental Investors Fund
|
344
|
units
|
$
|
18,784
|
$
|
26,064
|
|||||||||||
BlackRock US Government Bond Portfolio
|
347
|
units
|
$
|
3,753
|
$
|
3,734
|
|||||||||||
ClearBridge Large Cap Growth Fund (IS)
|
222
|
Units
|
$
|
$
|
12,409
|
$
|
16,619
|
||||||||||
Eaton Vance AtlCapSMID-Cap
|
97
|
units
|
$
|
3,257
|
$
|
3,999
|
|||||||||||
Janus Triton Fund (I)
|
87
|
units
|
$
|
2,748
|
$
|
2,976
|
|||||||||||
Janus Henderson Balanced Fund (N)
|
338
|
units
|
$
|
12,455
|
$
|
15,533
|
|||||||||||
MFS International Value R4 Fund
|
109
|
units
|
$
|
4,755
|
$
|
5,792
|
|||||||||||
MFS International Value R6 Fund
|
293
|
units
|
$
|
6,717
|
$
|
7,118
|
|||||||||||
Prudential Total Return Bond Fund
|
613
|
units
|
$
|
8,918
|
$
|
8,870
|
|||||||||||
Vanguard Life Strategy Conservative Growth Fund
|
244
|
units
|
$
|
4,964
|
$
|
5,627
|
|||||||||||
(a)
|
(b)
|
(c)
|
(d)
|
(e)
|
||||||||||
Identity of issue, borrower,
lessor or similar party
|
Description of investment/interest
|
Cost
|
Current Value
|
|||||||||||
Vanguard Life Strategy Growth Fund
|
140
|
units
|
$
|
4,781
|
$
|
6,231
|
||||||||
Vanguard Life Strategy Moderate Growth Fund
|
414
|
units
|
$
|
10,807
|
$
|
13,901
|
||||||||
Mutual Fund Window
|
||||||||||||||
TD Ameritrade Participant-Directed Brokerage Account
|
Various mutual fund investments
|
$
|
1,578
|
$
|
1,578
|
|||||||||
Total Mutual Funds
|
$
|
97,846
|
$
|
120,242
|
||||||||||
TD Ameritrade Participant-Directed Brokerage Account
|
Various common stock investments
|
$
|
788
|
$
|
788
|
|||||||||||
*
|
MTI Common Stock Fund
|
|||||||||||||||
Minerals Technologies Inc.
|
||||||||||||||||
Common Stock
|
566
|
units
|
$
|
30,186
|
$
|
41,380
|
||||||||||
Pfizer Common Stock Fund
|
||||||||||||||||
Pfizer Inc. Common Stock
|
252
|
units
|
$
|
6,151
|
$
|
14,881
|
||||||||||
Total Common Stock
|
$
|
37,125
|
$
|
57,049
|
||||||||||||
*
|
Notes receivable from participants
|
471 loans to participants with interest rates of 4.25% to 9.75% with various maturity dates through 2036
|
$
|
-
|
$
|
4,940
|
||||||||||
Total
|
$
|
367,788
|
By:
|
/s/ Matthew E. Garth
|
Matthew E. Garth
Senior Vice President - Finance and Treasury, Chief Financial Officer Member, Minerals Technologies Inc. Savings and Investment Plan Committee |
Exhibit Number
|
Exhibit Description
|
23.1
|